... underway o r reported in HAE therapyand these have led to the licensing o f pdC1INH in many parts of the world including Europe and the Uni-ted States, bradykinin receptor antagonist Icatibant in Europe, ... ViroPharma; Cetor-n®, Sanquin), recombinant C1-INH replacement therapy(conestat alfa; Rhucin®, Pharming), kallikrein inhibitor(Ecallantide , Kalbito r®, Dyax), and bradykinin- 2-recep torant ... Department of Internal Medicine,Faculty of Medicine, Semmelweis University, Budapest, Hungary.4Department of Dermatology, University Hospital of the JohannesGutenberg-University of Mainz, Mainz, Germany.5Department...